1. Home
2. BVIKM-SBIMC symposia
3. Symposia
4. 19th symposium

19th symposium

CONTROVERSIES AND COMPLEMENTARITY, OR WHAT DO WE REALLY LEARN FROM OUR NEIGHBOURS?

• Antimicrobial resistance and usage patterns in Europe: focus on Dutch-Belgian differences and complementarities. Lessons for the future. [Dominique MONNET (Statens Serum Institut, Kobnhavn, Denmark)
• MRSA control: which policy? [Andreas VOSS (Radboud UMC, Nijmegen, the Netherlands)]
• MRSA control: Belgian policy. [Marc STRUELENS (Hôpital Erasme - ULB, Brussels)]
• Microbiologist-infectiologist relationship: synergy or antagonism? [Dirk VOGELAERS (UZ Gent, Ghent)]
• Microbiologist-infectiologist relationship: synergy or antagonism? [Henri VERBRUGH (Erasmus MC, Rotterdam, the Netherlands)]
• HIV genotyping: yes or no? [Charles BOUCHER (UMC Utrecht, Utrecht, the Netherlands)]
• Genotypic resistance testing: yes or no? [Stéphane DE WIT (UMC Sint-Pieter - CHU Saint-Pierre, Brussels)]
• Surgical antimicrobial prophylaxis in the Netherlands. [Inge GYSSENS (Erasmus MC, Rotterdam, the Netherlands)]
• From national to local guidelines: prophylaxis in surgery. The Belgian experience. [Jean-Paul SION (AZ Monica, Antwerp)]
• Acute exacerbations of COPD: the Dutch perspective. [Andy HOEPELMAN (UMC Utrecht, Utrecht, the Netherlands)]
• Acute exacerbations of COPD: the Belgian perspective. [Yvan VALCKE (AZ Maria Middelares, Sint-Niklaas)]
• MIC based therapies: why bother? [Henri VERBRUGH (Canisius Wilhelmina Ziekenhuis, Nijmegen, the Netherlands)]
• MIC based therapies. [Willy PEETERMANS (UZ Leuven, Leuven)]